FDA Blocks COVID and Shingles Vaccine Study Release
The FDA has withdrawn studies on COVID-19 and shingles vaccines, citing unsupported conclusions. This controversial decision raises questions about vaccine safety narratives under HHS Secretary Robert F. Kennedy Jr.
Controversy Surrounding Vaccine Studies
The FDA's recent decision to withdraw studies tracking the safety of COVID-19 and shingles vaccines has sparked significant debate. According to a spokesperson from the Department of Health and Human Services (HHS), the studies were retracted because the authors made broad conclusions that did not align with the data. This move is seen as an effort to maintain the integrity of the FDA's scientific process.
Critics argue that this decision reflects a troubling trend under HHS Secretary Robert F. Kennedy Jr., who has been vocal about his skepticism towards vaccine safety. Notably, Kennedy has previously made claims that the COVID-19 vaccine is the "deadliest vaccine ever made," despite extensive research showing that COVID vaccines are among the most studied in history, with benefits far outweighing risks.
- •Key points of concern include:
- •Withdrawal of studies that contradict the anti-vaccine narrative.
- •Cancellation of $500 million in mRNA vaccine development funding.
- •Replacement of CDC vaccine advisory committee members with skeptics.
These actions have raised alarms among health officials and experts, who warn that such censorship could undermine public trust in vaccines and hinder future pandemic preparedness.